# Biodesix Inc: filings

BDSX · Nasdaq · CIK 1439725 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bdsx.md) · [Financials](/companies/bdsx/financials.md) · [Filings](/companies/bdsx/filings.md) · [Insiders](/companies/bdsx/insiders.md)

## Reports and events: 114 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 318, 8-K 54, D 20, 10-Q 18, 144 17, 3 15, CORRESP 14, SC 13D/A 14, UPLOAD 11, 424B5 8, EFFECT 7, S-8 7, SC 13G 7, SC 13G/A 7, 10-K 6, DEF 14A 6, S-1/A 5, S-3 5, SCHEDULE 13G 5, ARS 4, D/A 4, DEFA14A 4, SC 13D 4, SCHEDULE 13D/A 4, SCHEDULE 13G/A 4, 424B3 3, PRE 14A 3, 4/A 2, S-1 2, SC TO-I/A 2, SEC STAFF LETTER 2, 424B4 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, DRS/A 1, DRSLTR 1, S-3/A 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 20:05 ET | [10-Q](/filings/0001193125-26-335036.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335036 |
| 2026-08-05 | 20:02 ET | [8-K](/filings/0001193125-26-335010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-335010 |
| 2026-05-20 | 20:18 ET | [8-K](/filings/0001193125-26-232631.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-232631 |
| 2026-05-04 | 20:05 ET | [10-Q](/filings/0001193125-26-203960.md) | Quarterly report, period 2026-03-31 | 0001193125-26-203960 |
| 2026-05-04 | 20:03 ET | [8-K](/filings/0001193125-26-203936.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-203936 |
| 2026-04-09 | 20:14 ET | [DEF 14A](/filings/0001193125-26-149633.md) | Proxy statement, period 2026-05-19 | 0001193125-26-149633 |
| 2026-02-26 | 21:06 ET | [10-K](/filings/0001193125-26-076547.md) | Annual report, period 2025-12-31 | 0001193125-26-076547 |
| 2026-02-26 | 21:02 ET | [8-K](/filings/0001193125-26-076521.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076521 |
| 2026-01-27 | 19:28 ET | [SCHEDULE 13D/A](/filings/0000905148-26-000363.md) | Ownership report, active investor, amended | 0000905148-26-000363 |
| 2026-01-12 | 17:04 ET | [8-K/A](/filings/0001193125-26-010114.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-010114 |
| 2025-11-03 | 21:05 ET | [10-Q](/filings/0001193125-25-262532.md) | Quarterly report, period 2025-09-30 | 0001193125-25-262532 |
| 2025-11-03 | 21:02 ET | [8-K](/filings/0001193125-25-262508.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-262508 |
| 2025-10-01 | 20:05 ET | [8-K](/filings/0001193125-25-226749.md) | 8.01 Other events | 0001193125-25-226749 |
| 2025-09-23 | 13:29 ET | [SCHEDULE 13D/A](/filings/0000905148-25-003393.md) | Ownership report, active investor, amended | 0000905148-25-003393 |
| 2025-09-15 | 21:01 ET | [8-K](/filings/0001193125-25-203746.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-203746 |
| 2025-09-11 | 12:00 ET | [8-K](/filings/0001193125-25-200766.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-200766 |
| 2025-09-03 | 20:43 ET | [SCHEDULE 13D/A](/filings/0000905148-25-003282.md) | Ownership report, active investor, amended | 0000905148-25-003282 |
| 2025-08-07 | 20:11 ET | [10-Q](/filings/0000950170-25-105026.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105026 |
| 2025-08-07 | 20:05 ET | [8-K](/filings/0001439725-25-000003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001439725-25-000003 |
| 2025-05-21 | 20:43 ET | [8-K](/filings/0001193125-25-124047.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-124047 |
| 2025-05-20 | 20:11 ET | [SCHEDULE 13D/A](/filings/0000905148-25-001862.md) | Ownership report, active investor, amended | 0000905148-25-001862 |
| 2025-05-13 | 20:10 ET | [10-Q](/filings/0000950170-25-070339.md) | Quarterly report, period 2025-03-31 | 0000950170-25-070339 |
| 2025-05-13 | 20:05 ET | [8-K](/filings/0000950170-25-070292.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-070292 |
| 2025-04-28 | 20:06 ET | [DEF 14A](/filings/0001193125-25-100458.md) | Proxy statement, period 2025-05-20 | 0001193125-25-100458 |
| 2025-04-17 | 20:08 ET | [8-K](/filings/0001193125-25-084319.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-084319 |
| 2025-03-28 | 20:01 ET | [8-K](/filings/0000950170-25-046748.md) | 3.01 Delisting notice | 0000950170-25-046748 |
| 2025-03-03 | 21:05 ET | [10-K](/filings/0000950170-25-030835.md) | Annual report, period 2024-12-31 | 0000950170-25-030835 |
| 2025-03-03 | 21:03 ET | [8-K](/filings/0000950170-25-030814.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-030814 |
| 2025-01-10 | 11:05 ET | [8-K](/filings/0000950170-25-003717.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-003717 |
| 2024-11-01 | 10:08 ET | [10-Q](/filings/0000950170-24-119792.md) | Quarterly report, period 2024-09-30 | 0000950170-24-119792 |
| 2024-11-01 | 10:05 ET | [8-K](/filings/0000950170-24-119791.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-119791 |
| 2024-08-15 | 01:22 ET | [8-K](/filings/0001193125-24-200857.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-200857 |
| 2024-08-07 | 20:08 ET | [10-Q](/filings/0000950170-24-092773.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092773 |
| 2024-08-07 | 20:02 ET | [8-K](/filings/0000950170-24-092722.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092722 |
| 2024-05-24 | 20:11 ET | [S-1/A](/filings/0001193125-24-147047.md) | Registration statement, amended | 0001193125-24-147047 |
| 2024-05-23 | 23:10 ET | [SC 13D/A](/filings/0001140361-24-027326.md) | Ownership report, active investor, amended | 0001140361-24-027326 |
| 2024-05-23 | 23:09 ET | [SC 13D/A](/filings/0001140361-24-027325.md) | Ownership report, active investor, amended | 0001140361-24-027325 |
| 2024-05-23 | 20:10 ET | [8-K](/filings/0001193125-24-145965.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-145965 |
| 2024-05-08 | 20:10 ET | [10-Q](/filings/0000950170-24-055651.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055651 |
| 2024-05-08 | 20:05 ET | [8-K](/filings/0000950170-24-055608.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-055608 |
| 2024-04-26 | 20:13 ET | [DEF 14A](/filings/0001193125-24-118069.md) | Proxy statement, period 2024-05-21 | 0001193125-24-118069 |
| 2024-04-23 | 20:18 ET | [S-1](/filings/0001193125-24-107051.md) | Registration statement | 0001193125-24-107051 |
| 2024-04-09 | 00:25 ET | [SC 13D/A](/filings/0001140361-24-018955.md) | Ownership report, active investor, amended | 0001140361-24-018955 |
| 2024-04-09 | 00:25 ET | [SC 13D/A](/filings/0001140361-24-018954.md) | Ownership report, active investor, amended | 0001140361-24-018954 |
| 2024-04-09 | 23:45 ET | [SC 13D/A](/filings/0001140361-24-018946.md) | Ownership report, active investor, amended | 0001140361-24-018946 |
| 2024-04-09 | 23:40 ET | [SC 13D/A](/filings/0001140361-24-018943.md) | Ownership report, active investor, amended | 0001140361-24-018943 |
| 2024-04-09 | 20:07 ET | [8-K](/filings/0001193125-24-090787.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-090787 |
| 2024-03-01 | 11:11 ET | [10-K](/filings/0000950170-24-023513.md) | Annual report, period 2023-12-31 | 0000950170-24-023513 |
| 2024-03-01 | 11:05 ET | [8-K](/filings/0000950170-24-023509.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-023509 |
| 2023-12-20 | 14:19 ET | [8-K](/filings/0000950170-23-071761.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-23-071761 |

Page 1 of 3. [Older](/companies/bdsx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.